Pricing Log in Create free account

Caribou Biosciences, Inc. (CRBU) vs Sangamo Therapeutics, Inc. (SGMOQ)

Caribou Biosciences, Inc. and Sangamo Therapeutics, Inc. are both Biotechnology companies. Caribou Biosciences, Inc. and Sangamo Therapeutics, Inc. are of similar size ($44.2M and $41.9M). Caribou Biosciences, Inc. grew revenue faster over the last twelve months: 1.60% against −45.8%. Sangamo Therapeutics, Inc. has the higher net margin (−356.9% vs −1,085.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Sangamo Therapeutics, Inc. leads on 8 and Caribou Biosciences, Inc. on 6.

Valuation

Metric CRBU SGMOQ Biotechnology median
P/E n/m n/m 10.60
P/S 5.01 1.24 9.40
P/B 0.62 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.45 n/m 0.66
EV/Sales (5.03) 1.24 9.02
Earnings yield (234.09%) (345.45%) (32.88%)
Free cash flow yield (275.02%) (211.06%) (23.13%)

Profitability

Metric CRBU SGMOQ Biotechnology median
Gross margin 100.00% 100.00% 68.51%
Operating margin (1,140.55%) (357.55%) 0.00%
Net margin (1,085.00%) (356.89%) 0.00%
Free cash flow margin (985.95%) (261.76%) 0.00%
Return on equity (93.80%) 1,755.72% (51.96%)
Return on assets (64.44%) (168.79%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CRBU SGMOQ Biotechnology median
Revenue growth (TTM) 1.60% (45.80%) 6.76%
EPS growth (last fiscal year) 3.64% 10.20% 29.88%
Revenue growth, 5-year CAGR (2.03%) (19.66%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRBU SGMOQ Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.97 0.70 4.97
Net debt to EBITDA 0.96 0.18 1.01

Dividend

Metric CRBU SGMOQ Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CRBU SGMOQ Biotechnology median
Market cap 44.20m 41.89m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack